相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
4°C, sealed storage, away from moisture and light
- 英文名:
CS-514 sodium
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- 规格:
10 mM * 1 mL/5 mg/10 mg/50 mg/100 mg/200 mg/500 mg/1 g/5 g/10 g
| 规格: | 10 mM * 1 mL | 产品价格: | ¥500.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥233.0 |
| 规格: | 10 mg | 产品价格: | ¥349.0 |
| 规格: | 50 mg | 产品价格: | ¥640.0 |
| 规格: | 100 mg | 产品价格: | ¥950.0 |
| 规格: | 200 mg | 产品价格: | ¥1300.0 |
| 规格: | 500 mg | 产品价格: | ¥1950.0 |
| 规格: | 1 g | 产品价格: | ¥2535.0 |
| 规格: | 5 g | 产品价格: | ¥4056.0 |
| 规格: | 10 g | 产品价格: | ¥5273.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Pravastatin sodium
CAS No. : 81131-70-6
MCE 国际站:Pravastatin sodium
产品活性:Pravastatin sodium (CS-514 sodium) 是 HMG-CoA 还原酶抑制剂,对甾醇合成的 IC50 为 5.6 μM。
研究领域:Metabolic Enzyme/Protease | Autophagy | Apoptosis
作用靶点:HMG-CoA Reductase (HMGCR) | Autophagy | Ferroptosis
In Vitro: Pravastatin (CS-514) is a member of the drug class of statins, used in combination with diet, exercise, and weight-loss for lowering cholesterol and preventing cardiovascular disease.
相关产品:Natural Product Library Plus | Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Apoptosis Compound Library | Metabolism/Protease Compound Library | Natural Product Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | Antiviral Compound Library | Autophagy Compound Library | Drug Repurposing Compound Library | Anti-Cardiovascular Disease Compound Library | Ferroptosis Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Cancer Metabolism Compound Library | Microbial Metabolite Library | Lipid Metabolism Compound Library | Rare Diseases Drug Library | Children’s Drug Library | Anti-Cancer Natural Product Library | EMA-Approved Drug Library | FDA-Approved Anticancer Drug Library | Human Metabolite Library | Anti-Pulmonary Fibrosis Compound Library | Off-patent Drug Library | Cell Death Library | Ferrostatin-1 | Erastin | Cisplatin | Cycloheximide | RSL3 | Acetylcysteine | Sorafenib | ML385 | Necrostatin-1 | SP600125 | Rosiglitazone | Liproxstatin-1 | Curcumin | Simvastatin | Hemin | TBHQ | Lapatinib | Roxadustat | L-Glutathione reduced | Trolox | Lovastatin | Sulfasalazine | NADPH tetrasodium salt | U-73122 | Pifithrin-α hydrobromide | Pioglitazone | iFSP1 | Atorvastatin hemicalcium salt | FIN56 | Baicalein
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验酶,抑制其活性可阻抑肝细胞合成胆固醇,使胆固醇含量减少。HMG-CoA抑制剂亦称他汀类(statins)药物,1976年被Endo等从霉菌的培养液中获得,是目前治疗高胆固醇血症(Hypercholesterolemia)的新型药物。其中美伐他汀(mevastatin)和洛伐他汀(lovastatin)是从真菌培养物中分离而来的。普伐他汀(pravastatin)和辛伐他汀(simvastatin)为人工半合成品。氟伐他汀(fluvastatin)和阿伐他汀(atorvastatin)是新近人工
mmHg以下者的比例。 表1 的数据表明,目前我国人群高血压患者的高血压知晓率、治疗(服药)率和控制率都很低。此外,农村的相应各率明显低于城市,男性低于女性。美国20世纪80年代的资料显示,人群高血压患者知晓率为60%,服药率为40%,控制率达25%;2000年以上三率分别达70%,59%和34%。 以上流行病学资料显示,近半个世纪来我国人群高血压患病率上升很快。其他研究资料还表明,心血管病的其他危险因素(血脂异常、肥胖、糖尿病、吸烟等)也呈明显上升趋势,加快了高血压的致病过程。导致高血
技术资料暂无技术资料 索取技术资料
















